Avid Bioservices Inc News - CDMOP

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in...

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics...

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics...

Avid Bioservices to Participate at Upcoming Investor Conferences

TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics...

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in...

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated...

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated...

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated...

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated...

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

-- Recorded Second Quarter Revenue of $25.4 Million -- -- Signed $35 Million in Net New Business Orders...

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

TUSTIN, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics...

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Avid Bioservices Inc (CDMOP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CDMOP News

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

Avid Bioservices to Participate at Upcoming Investor Conferences

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023

CDMOP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Avid Bioservices Inc (CDMOP) News

Avid Bioservices Inc (CDMOP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CDMOP News

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

Avid Bioservices to Participate at Upcoming Investor Conferences

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

Avid Bioservices Announces Proposed Private Placement of Convertible Notes

Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility

Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023

CDMOP Discussion

Your Recent History